PBMCs obtained from 11 patients with CLL were treated with relatlimab and T cell production of TNF-α, IFN-γ and IL-2 was measured by intracellular staining and flow cytometry analysis (Figure 6). Here, TNF is linked to B-cell chronic lymphocytic leukemia.